ArticleScience translational medicine2013

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.

Brian J Cameron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.